HomeBSLN • SWX
add
Basilea Pharmaceutica AG Allschwil
Nakaraang pagsara
CHF 43.10
Sakop ng araw
CHF 42.95 - CHF 43.50
Sakop ng taon
CHF 36.75 - CHF 48.75
Market cap
567.71M CHF
Average na Volume
44.48K
P/E ratio
7.70
Dividend yield
-
Primary exchange
SWX
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CHF) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 66.12M | 81.84% |
Gastos sa pagpapatakbo | 7.98M | 0.24% |
Net na kita | 28.43M | 365.82% |
Net profit margin | 42.99 | 246.17% |
Kita sa bawat share | — | — |
EBITDA | 26.89M | 464.63% |
Aktuwal na % ng binabayarang buwis | -7.41% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CHF) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 120.71M | 101.41% |
Kabuuang asset | 257.76M | 48.75% |
Kabuuang sagutin | 176.76M | -3.56% |
Kabuuang equity | 81.00M | — |
Natitirang share | 12.13M | — |
Presyo para makapag-book | 6.45 | — |
Return on assets | 25.30% | — |
Return on capital | 33.85% | — |
Cash Flow
Net change in cash
| (CHF) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 28.43M | 365.82% |
Cash mula sa mga operasyon | 28.22M | 840.82% |
Cash mula sa pag-invest | -636.00K | -97.21% |
Cash mula sa financing | -11.00K | 99.95% |
Net change in cash | 27.54M | 213.29% |
Malayang cash flow | 17.85M | 533.14% |
Tungkol
Basilea Pharmaceutica is a biopharmaceutical company based in Allschwil near Basel, Switzerland. Basilea was spun off from F. Hoffmann-La Roche in 2000 and has been listed as an independent company on the Swiss stock exchange since March 2004. The company's subsidiary is Basilea Pharmaceutica International AG, Allschwil, which is also based in Allschwil, Switzerland, and in which the company's operating activities are bundled. Wikipedia
CEO
Itinatag
2000
Website
Mga Empleyado
164
